← Back to Screener
Quest Diagnostics Inc. (DGX)
Price$191.46
Favorite Metrics
Price vs S&P 500 (26W)1.84%
Price vs S&P 500 (4W)-7.77%
Market Capitalization$21.07B
P/E Ratio (Annual)21.24x
Indicated Dividend Yield (Annual)1.80%
All Metrics
P/CF (Annual)11.17x
Book Value / Share (Quarterly)$65.18
P/TBV (Annual)3.49x
Indicated Dividend (Annual)$3.20
Revenue Growth (3Y)3.74%
Cash Flow / Share (Quarterly)$12.35
Payout Ratio (TTM)35.58%
Price vs S&P 500 (YTD)7.67%
Gross Margin (TTM)33.32%
Net Profit Margin (TTM)8.99%
EPS (TTM)$8.78
10-Day Avg Trading Volume0.75M
EPS Excl Extra (TTM)$8.78
Revenue Growth (5Y)3.18%
EPS (Annual)$8.78
Dividend / Share (Annual)$3.19
ROI (Annual)7.61%
Gross Margin (Annual)33.32%
Net Profit Margin (5Y Avg)11.02%
Cash / Share (Quarterly)$3.82
P/E Basic Excl Extra (TTM)21.24x
Revenue Growth QoQ (YoY)7.06%
EPS Growth (5Y)-3.56%
P/E Normalized (Annual)21.24x
ROA (Last FY)6.11%
Revenue Growth TTM (YoY)11.78%
EBITD / Share (TTM)$15.19
ROE (5Y Avg)17.45%
Operating Margin (TTM)14.10%
Cash Flow / Share (Annual)$12.35
P/B Ratio2.94x
P/B Ratio (Quarterly)2.69x
Net Income / Employee (Annual)$0
EV / Revenue (TTM)2.38x
Net Interest Coverage (TTM)6.38x
ROA (TTM)6.18%
EPS Growth QoQ (YoY)13.29%
EV / EBITDA (TTM)15.33x
EPS Incl Extra (Annual)$8.78
Current Ratio (Annual)1.04x
Quick Ratio (Quarterly)0.80x
3-Month Avg Trading Volume0.95M
52-Week Price Return13.94%
EV / Free Cash Flow (Annual)19.37x
P/E Incl Extra (TTM)21.24x
Revenue / Employee (TTM)$0
Tangible BV / Share (Quarterly)$50.31
P/S Ratio (Annual)1.91x
Asset Turnover (Annual)0.68x
52-Week High$213.50
Operating Margin (5Y Avg)15.58%
EPS Excl Extra (Annual)$8.78
CapEx CAGR (5Y)4.74%
Tangible BV CAGR (5Y)-0.21%
26-Week Price Return5.82%
Quick Ratio (Annual)0.80x
13-Week Price Return8.80%
Total Debt / Equity (Annual)0.82x
Current Ratio (Quarterly)1.04x
Enterprise Value$26,317.867
Revenue / Share Growth (5Y)7.07%
Asset Turnover (TTM)0.69x
Book Value / Share Growth (5Y)5.10%
Revenue / Employee (Annual)$0
Inventory Turnover (Annual)39.03x
Pretax Margin (Annual)11.94%
Cash / Share (Annual)$3.82
3-Month Return Std Dev24.88%
Gross Margin (5Y Avg)34.87%
Net Income / Employee (TTM)$0
EBITDA CAGR (5Y)-4.40%
EBITDA Interim CAGR (5Y)-12.26%
ROE (Last FY)13.84%
Net Interest Coverage (Annual)6.38x
EPS Basic Excl Extra (Annual)$8.78
P/FCF (TTM)15.50x
Receivables Turnover (TTM)8.14x
EV / Free Cash Flow (TTM)19.37x
Total Debt / Equity (Quarterly)0.79x
EPS Incl Extra (TTM)$8.78
Receivables Turnover (Annual)8.14x
ROI (TTM)7.71%
Dividend Growth Rate (5Y)7.42%
P/S Ratio (TTM)1.91x
Pretax Margin (5Y Avg)14.53%
Revenue / Share (Annual)$97.65
Tangible BV / Share (Annual)$50.31
Forward P/E18.01x
Free OCF CAGR (5Y)-3.05%
Price vs S&P 500 (52W)-15.89%
P/E Ratio (TTM)21.24x
EPS Growth TTM (YoY)14.15%
Year-to-Date Return10.31%
5-Day Price Return-3.24%
EPS Normalized (Annual)$8.78
ROA (5Y Avg)7.92%
Net Profit Margin (Annual)8.99%
Month-to-Date Return-2.33%
Cash Flow / Share (TTM)$10.91
EBITD / Share (Annual)$15.19
EPS Growth (3Y)3.07%
Operating Margin (Annual)14.10%
LT Debt / Equity (Annual)0.72x
P/CF (TTM)11.17x
ROI (5Y Avg)10.05%
P/E Excl Extra (TTM)21.24x
LT Debt / Equity (Quarterly)0.72x
EPS Basic Excl Extra (TTM)$8.78
P/TBV (Quarterly)3.49x
Payout Ratio (Annual)35.58%
P/B Ratio (Annual)2.69x
Dividend / Share (TTM)$3.19
Inventory Turnover (TTM)39.03x
Pretax Margin (TTM)11.94%
Book Value / Share (Annual)$65.18
Price vs S&P 500 (13W)8.11%
Net Margin Growth (5Y)-9.92%
Dividend Yield (TTM)1.68%
Beta0.62x
P/FCF (Annual)15.50x
Revenue / Share (TTM)$97.65
ROE (TTM)13.88%
52-Week Low$160.02
Analyst Recommendations
Jan 2026
Feb 2026
Mar 2026
Apr 2026
3.75
3.79
3.79
3.79
Industry Peers — Health Services(20)
| Symbol | P/E Ratio (Annual) | Revenue Growth TTM (YoY) | Operating Margin (TTM) | ROE (TTM) | Price |
|---|---|---|---|---|---|
DGXQuest Diagnostics Inc. | 21.24x | 11.78% | 14.10% | 13.88% | $191.46 |
NTRANatera, Inc. Common Stock | — | 35.90% | -13.44% | -15.28% | $196.11 |
LHLabcorp Holdings Inc. | 25.08x | 7.25% | 9.92% | 10.28% | $266.36 |
EXASExact Sciences Corp | — | 17.69% | -6.35% | -8.51% | $104.91 |
GHGuardant Health, Inc. Common Stock | — | 32.88% | -45.02% | -246.60% | $85.70 |
RDNTRadNet, Inc. Common Stock | 1779.27x | 11.51% | 3.04% | -1.88% | $60.09 |
VCYTVeracyte, Inc. | 40.04x | 16.01% | 11.17% | 5.33% | $33.03 |
GRALGRAIL, Inc. Common Stock | — | 17.18% | -381.98% | -17.11% | $49.47 |
CDNACareDx, Inc. | 18.34x | 13.79% | -8.10% | -6.47% | $22.42 |
FTREFortrea Holdings Inc. Common Stock | — | 1.00% | -32.04% | -152.17% | $10.09 |
CSTLCastle Biosciences, Inc. Common Stock | 47.31x | 3.66% | -12.44% | -5.27% | $24.56 |
About
Quest Diagnostics is the leading independent provider of diagnostic testing services in the United States, generating over 97% of revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse screening delivered via a nationwide network of approximately 2,400 patient service centers and partnerships with healthcare providers. The company's diagnostic solutions segment provides supplementary services including clinical trials testing, risk-assessment services, and healthcare information technology solutions.